Home > Insider Trading > Biomarin Pharmaceutical Inc

Biomarin Pharmaceutical Inc (BMRN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Should You Hold BioMarin Pharmaceutical (BMRN) Despite Setback?

Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

June 20th, 2024 - Hedge Fund Investor Letters News

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript

BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc.

Keep Reading →

April 26th, 2024 - News Transcripts

30 Biggest Biotechnology Companies in the World

In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.

Keep Reading →

March 17th, 2024 - Lists News

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript

BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $0.18 EPS, expectations were $0.44.

Keep Reading →

February 23rd, 2024 - News Transcripts

20 Fastest Growing Biotech Companies in the US

In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.

Keep Reading →

February 23rd, 2024 - Lists News

Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks

In this article, we discuss the 5 stocks receiving price-target cut from analysts.

Keep Reading →

January 31st, 2024 - Market Movers News

Billionaire Louis Bacon's 10 Stock Picks with Huge Upside Potential

In this article, we discuss billionaire Louis Bacon's 10 stock picks with huge upside potential. To skip the details about Mr.

Keep Reading →

December 5th, 2023 - Hedge Funds News

Top 20 Drug Companies in the US by Revenue

Following the Covid-19 pandemic, which drastically altered the way of living, the top pharmaceutical or drug companies in the world became the center of attention for people everywhere due to the spike...

Keep Reading →

November 9th, 2023 - Industries Lists News

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q3 2023 Earnings Call Transcript

Operator: Hello and welcome to the BioMarin Pharmaceutical Third Quarter 2023 Conference Call. All lines have been placed on meet to prevent any background noise.

Keep Reading →

November 2nd, 2023 - News Transcripts